Degroof Petercam - Home Invest Belgium SA (HOMI) Home Invest Belgium - Secures EUR 160m in long term financing

Report

Degroof Petercam

Vincent Koppmair

Home Invest Belgium - Secures EUR 160m in long term financing

• HOMI secures EUR 160m in long-term financing to (i) refinance all bank loans & bonds maturing in 2024 and H1 2025 (ca. EUR 135m) and (ii) fully finance the ongoing development pipeline (EUR 25m).• Additionally, HOMI also took the opportunity to update its Green Finance Framework to include the latest developments.• We reiterate our 'Hold' rating and EUR 18.00 TP.

19/01/2024 1 EN

Underlying

Home Invest Belgium SA

Home Invest Belgium SA is a public regulated real estate company based in Belgium. The Company specializes in the acquisition, sale, development and management of residential real estate properties. It holds a wide portfolio of properties located on strategic locations in Belgium and The Netherlands. The Comapny's oerates throught its subsidiares such as Clarestates BV.

See profile

BE0003760742 Euronext Brussels Belgium

Provider

Degroof Petercam

We are an investment house with Belgian roots founded on more than 150 years of trust.

As a private company owned by long-term committed shareholders, we are independent. Naturally and structurally. Our experts have the knowledge to think and act without bias, and to make decisions that benefit our clients. Today and tomorrow.

See profile

Analysts

Vincent Koppmair

Other Reports on these Companies

Degroof Petercam

Home Invest Belgium - Q1 2024 - Stellar start to the year

EPRA results is up 12% YoY due to higher rental income and improved operating margin, EPS up 1.5% from the dilution impact of 2023's ABB.LTV down ca. 300bps to 47% due to disposals (EUR 40m) and positive revaluation (+6.7% / EUR +50m).We raise our TP to EUR 20.50 (from EUR 18.00) and upgrade HOMI to ‘Buy' (from ‘Hold'). Our TP implies a 17% upside potential.More details in our Note published this morning

May 23, 2024 May 23, 2024 1 EN

Degroof Petercam

Home Invest Belgium - Optional dividend & +6.7% portfolio valuation

HOMI proposes an optional dividend at an EGM on 24 May.Positive portfolio valuation of 6.7% in Q1 2024.We reiterated our ‘Hold' rating and EUR 18.00 TP.More details in our Note published this morning

April 25, 2024 April 25, 2024 1 EN

SmartInsider

Home Invest Belgium NV: 1 director

A director at Home Invest Belgium NV bought 1,025,850 shares at 13.080EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The ...

Free Trial

April 24, 2024 April 24, 2024 1 EN

(Sponsored) Cabka - Slower margin recovery, dividend cut

2024 revenues in line and gross margin a touch below our estimate, EBITDA-margin of 11-12% below guidance of ca 13% (DP: 13.6%)Changes capital allocation, no dividend over 2024, which we consider positiveWe will modestly cut out 2024 and 2025 estimates

February 21, 2025 February 21, 2025 1 EN

Fernand de Boer

Fernand de Boer

ForFarmers - Leading in a consolidating feed market

We upgrade ForFarmers to from Hold to Buy, for the following reasons:Management successfully turns around the company. Under the helm of new management ForFarmers has been delivering on its strategy in the past few years, resulting in improving key positions through selective M&A with a focus on growth metrics such as free cash flow generation and EBITDA. It also has strengthened its market segments like poultry, horse and organic feed. Team agrar & HaBeMa boosting EBITDA by 25-30%. In 2024, ForFarmers announced the JV with team agrar and to fully consolidate HaBeMa. We expect this to boost EB...

February 18, 2025 February 18, 2025 1 EN

Research Team

Research Team

(Sponsored) Luxempart - Family-owned compounder with strong track record

Luxempart has a ~15% IRR over the last 30 years, which is a very impressive track record for any investment company in EuropeAfter the Nexus AG tender, Luxempart's war chest would still be more than EUR 300m (almost 10% of its portfolio) positioning it well for any investment opportunityAny event that would improve the liquidity of the stock would serve as a significant catalyst in our view to narrow its discountWe estimate the current NAV to be EUR 113.9 p/s, implying a discount of 38%. TP goes to EUR 88 (from EUR 94). With ~25% of upside, this is an

January 13, 2025 January 13, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Home Invest Belgium - Secures EUR 160m in long term financing

Home Invest Belgium - Q1 2024 - Stellar start to the year

Home Invest Belgium - Optional dividend & +6.7% portfolio valuation

Home Invest Belgium NV: 1 director

(Sponsored) Cabka - Slower margin recovery, dividend cut

ForFarmers - Leading in a consolidating feed market

(Sponsored) Luxempart - Family-owned compounder with strong track record

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe